Efficacy and Safety of Granulocyte-colony Stimulating Factor in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid: A Randomized, Double-blind, Placebo-controlled, Nationwide Multi-center Study
Phase of Trial: Phase III
Latest Information Update: 10 May 2016
At a glance
- Drugs Filgrastim (Primary)
- Indications Alcoholic hepatitis
- Focus Therapeutic Use
- 01 Dec 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov record.
- 06 Jul 2015 Planned initiation date changed from 1 Jun 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 06 Jul 2015 Planned number of patients changed from 240 to 268 as reported by ClinicalTrials.gov record.